androsterone glucuronide has been researched along with Polycystic Ovary Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lobo, RA; Saxena, T; Stanczyk, FZ | 1 |
| Holm, G; Janson, PO; Jedel, E; Labrie, F; Lind, AK; Nilsson, L; Odén, A; Ohlsson, C; Stener-Victorin, E | 1 |
| Chang, L; Duffy, DM; Legro, RS; Lobo, RA; Stanczyk, FZ | 1 |
| Carmina, E; Gentzchein, E; Lobo, RA; Stanczyk, FZ | 1 |
| Carmina, E; Cassidenti, DL; Gentzschein, E; Lobo, RA; Miles, RA; Stanczyk, FZ | 1 |
| Bray, CS; Franks, S; Kiddy, DS; Mason, HD; Polson, DW; Reed, MJ; Scanlon, MF; Sharp, PS; White, DM | 1 |
| Horton, N; Rittmaster, RS; Thompson, DL | 1 |
1 trial(s) available for androsterone glucuronide and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Acneiform Eruptions; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androsterone; Combined Modality Therapy; Electroacupuncture; Exercise; Female; Humans; Hyperandrogenism; Menstrual Cycle; Motor Activity; Oligomenorrhea; Polycystic Ovary Syndrome; Severity of Illness Index; Testosterone; Time Factors; Young Adult | 2011 |
6 other study(ies) available for androsterone glucuronide and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Topics: Adrenal Glands; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Case-Control Studies; Dehydroepiandrosterone Sulfate; Dexamethasone; Female; Humans; Hyperandrogenism; Ovary; Polycystic Ovary Syndrome; Testosterone; Treatment Outcome | 2014 |
Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
Topics: Administration, Cutaneous; Adolescent; Adult; Androstane-3,17-diol; Androsterone; Dihydrotestosterone; Female; Hirsutism; Humans; Infusions, Intravenous; Male; Middle Aged; Polycystic Ovary Syndrome; Prospective Studies; Reference Values; Splanchnic Circulation | 1995 |
Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
Topics: Adult; Androstane-3,17-diol; Androsterone; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate | 1995 |
Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
Topics: Administration, Cutaneous; Adult; Androstane-3,17-diol; Androstenedione; Androsterone; Cholestenone 5 alpha-Reductase; Female; Gels; Hirsutism; Humans; Male; Oxidoreductases; Polycystic Ovary Syndrome | 1992 |
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
Topics: Androgens; Androstenedione; Androsterone; Biological Transport; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Prevalence; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androsterone; Biomarkers; Dexamethasone; Female; Gonadotropin-Releasing Hormone; Hirsutism; Hormones; Humans; Leuprolide; Middle Aged; Ovary; Polycystic Ovary Syndrome; Radioimmunoassay | 1990 |